‪George D. Kalliolias M.D. Ph.D.‬

Citée par

	Toutes	Depuis 2019
Citations	3928	2312
indice h	25	20
indice i10	28	25

500

250

125

375

20072008200920102011201220132014201520162017201820192020202120222023202410 32 42 65 109 115 122 145 150 178 274 335 349 424 485 472 425 157

Accès public

Tout afficher

23 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Kyung-Hyun Park-MinHospital for Special SurgeryAdresse e-mail validée de hss.edu
Sungho parkUlsan National Institute of Science and TechnologyAdresse e-mail validée de unist.ac.kr
Stamatis-Nick C. LiossisProfessor of Medicine / Rheumatology, University of Patras Medical School, Patras, GreeceAdresse e-mail validée de med.upatras.gr
Athanasios G. PapavassiliouProfessor of Biological Chemistry, Medical School, National and Kapodistrian University of AthensAdresse e-mail validée de med.uoa.gr
Laura DonlinHospital for Special Surgery, Weill Cornell MedicineAdresse e-mail validée de hss.edu
Jane E SalmonHospital for Special Surgery - Weill Cornell Medical CollegeAdresse e-mail validée de hss.edu
Soumya RaychaudhuriHarvard Medical School; Brigham and Women's Hospital, Broad InstituteAdresse e-mail validée de broadinstitute.org
Kamil SlowikowskiMassachusetts General HospitalAdresse e-mail validée de broadinstitute.org
Deepak A. RaoAssistant Professor of Medicine, Brigham and Women's HospitalAdresse e-mail validée de bwh.harvard.edu
Fumitaka MizoguchiTokyo Medical and Dental UniversityAdresse e-mail validée de tmd.ac.jp
Peter A. Nigrovic, M.D.Harvard Medical SchoolAdresse e-mail validée de bwh.harvard.edu
Andrew FilerThe University of BirminghamAdresse e-mail validée de bham.ac.uk
Michael BrennerProfessor of Medicine, Harvard UniversityAdresse e-mail validée de research.bwh.harvard.edu
susan m goodmanAssociate Professor of Clinical MedicineAdresse e-mail validée de hss.edu
Christopher D BuckleyProfessorAdresse e-mail validée de kennedy.ox.ac.uk
Eugenia G GiannopoulouAssociate Professor, CityTech, City University of New YorkAdresse e-mail validée de citytech.cuny.edu
Andonopoulos A.Professor Emeritus, University of Patras, GreeceAdresse e-mail validée de upatras.gr
Yu QiaoHospital for Special SurgeryAdresse e-mail validée de hss.edu
Gerasimos SykiotisAssociate Professor and Senior Staff Physician, Lausanne University Hospital and University ofAdresse e-mail validée de chuv.ch
Anna NiarakisProfessor, HDR, University of Toulouse III- Paul SabatierAdresse e-mail validée de univ-evry.fr

Suivre

George D. Kalliolias M.D. Ph.D.

Asst Professor, Weill Cornell Medical College, Asst Scientist, Hospital for Special Surgery

Adresse e-mail validée de hss.edu

Rheumatology Immunology Rheumatoid Arthritis Cell Signaling Fibroblast-like synoviocytes


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
TNF biology, pathogenic mechanisms and emerging therapeutic strategies GD Kalliolias, LB Ivashkiv Nature reviews rheumatology 12 (1), 49-62, 2016	1269	2016
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis F Mizoguchi, K Slowikowski, K Wei, JL Marshall, DA Rao, SK Chang, ... Nature communications 9 (1), 789, 2018	424	2018
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis PDA Issuree, T Maretzky, DR McIlwain, S Monette, X Qing, PA Lang, ... The Journal of clinical investigation 123 (2), 928-932, 2013	193	2013
Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins L Wang, RA Gordon, L Huynh, X Su, KHP Min, J Han, JS Arthur, ... Immunity 32 (4), 518-530, 2010	159	2010
IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38 GD Kalliolias, LB Ivashkiv The Journal of Immunology 180 (9), 6325-6333, 2008	157	2008
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages A Triantafyllopoulou, CW Franzke, SV Seshan, G Perino, GD Kalliolias, ... Proceedings of the National Academy of Sciences 107 (7), 3012-3017, 2010	154	2010
Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts A Lee, Y Qiao, G Grigoriev, J Chen, KH Park‐Min, SH Park, LB Ivashkiv, ... Arthritis & Rheumatism 65 (4), 928-938, 2013	146	2013
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis GD Kalliolias, SN C Liossis Expert opinion on investigational drugs 17 (3), 349-359, 2008	133	2008
Overview of the biology of type I interferons GD Kalliolias, LB Ivashkiv Arthritis research & therapy 12, 1-9, 2010	126	2010
Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial GD Kalliolias, PE Georgiou, IA Antonopoulos, AP Andonopoulos, ... Annals of the Rheumatic Diseases 66 (6), 842-843, 2007	118	2007
Modulation of TNF-induced macrophage polarization by synovial fibroblasts LT Donlin, A Jayatilleke, EG Giannopoulou, GD Kalliolias, LB Ivashkiv The Journal of Immunology 193 (5), 2373-2383, 2014	114	2014
Interleukin‐27 inhibits human osteoclastogenesis by abrogating RANKL‐mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling GD Kalliolias, B Zhao, A Triantafyllopoulou, KH Park‐Min, LB Ivashkiv Arthritis & Rheumatism: Official Journal of the American College of …, 2010	102	2010
Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27 GD Kalliolias, RA Gordon, LB Ivashkiv The Journal of Immunology 185 (11), 7047-7056, 2010	89	2010
TNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysis C Loh, S Park, A Lee, R Yuan, LB Ivashkiv, GD Kalliolias Annals of the rheumatic diseases 78 (9), 1205-1214, 2019	78	2019
The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter‐regulated by … RA Gordon, G Grigoriev, A Lee, GD Kalliolias, LB Ivashkiv Arthritis & Rheumatism 64 (10), 3119-3128, 2012	78	2012
Prolonged tumor necrosis factor α primes fibroblast‐like synoviocytes in a gene‐specific manner by altering chromatin C Sohn, A Lee, Y Qiao, K Loupasakis, LB Ivashkiv, GD Kalliolias Arthritis & Rheumatology 67 (1), 86-95, 2015	76	2015
Pharmacogenetic principles in the Hippocratic writings GP Sykiotis, GD Kalliolias, AG Papavassiliou The Journal of Clinical Pharmacology 45 (11), 1218-1220, 2005	74	2005
Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease G Yiannopoulos, V Pastromas, I Antonopoulos, G Katsiberis, G Kalliolias, ... Rheumatology international 27, 357-361, 2007	66	2007
Kinase inhibitors: a new tool for the treatment of rheumatoid arthritis SD Chakravarty, PI Poulikakos, LB Ivashkiv, JE Salmon, GD Kalliolias Clinical Immunology 148 (1), 66-78, 2013	52	2013
The impact of disease activity and tumor necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis W HM, P N, L TJ, A A, K GD, Z YS, S F, N J, S L, Cunningham-Rundles S, ... Clin Exp Immunol., 2016	42	2016

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs